← Leaderboards
Dana Sarabeth Neel
University Of California, San Francisco
$170,990
Attributed
$170,990
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50K · FY2016–19$100K$75K$50K$25K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$170,990 · 1
By mechanism
F30$170,990 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Daniel B Vigneron$43,424,992
- Trever G Bivona$22,714,857
- Scarlett L Gomez$14,448,454
- William A Weiss$31,543,847
- Iona C Cheng$16,758,911
Others in their field
Top investigators on “Drug Resistance”
- Judith S. Currier · University Of California Los Angeles$207,752,958
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$145,910,108
- Ralph Parchment · Leidos Biomedical Research, Inc.$140,676,376
- Daniel R Kuritzkes · Brigham And Women'S Hospital$114,882,802
- Peter C Adamson · National Childhood Cancer Foundation$114,476,581
- Wafaa M. El-Sadr · Columbia University Health Sciences$113,453,088
Research focus
Drug ResistanceEpithelialDiagnosisAutomobile DrivingAmericanBindingApoptosisAllelesCancer Cell LineCancer EtiologyBaseCancer SubtypesCell GrowthCell LineCell ModelCell ProliferationCellsBiologicalCessation Of LifeClinicCombinatorialCombined Modality TherapyCancer PatientExhibits
Grant awards (4)
Dissecting the function of PI3K/mTOR pathway activation in ROS1 fusion-mediated oncogenesis and resistance to targeted therapy$50,016
F30 · FY2019 · CA · contact PI
Dissecting the function of PI3K/mTOR pathway activation in ROS1 fusion-mediated oncogenesis and resistance to targeted therapy$49,524
F30 · FY2018 · CA · contact PI
Dissecting the function of PI3K/mTOR pathway activation in ROS1 fusion-mediated oncogenesis and resistance to targeted therapy$35,959
F30 · FY2017 · CA · contact PI
Dissecting the function of PI3K/mTOR pathway activation in ROS1 fusion-mediated oncogenesis and resistance to targeted therapy$35,491
F30 · FY2016 · CA · contact PI